Fourteen-day vonoprazan-amoxicillin dual therapy versus 14-day bismuth-based quadruple therapy for treatment: a randomized clinical trial
Background: Potassium-competitive acid blockers (P-CABs) have shown potential in Helicobacter pylori ( H. pylori ) eradication, but the efficacy of dual therapy with P-CABs and amoxicillin remains underexplored. Objectives: This study evaluated the efficacy, safety, and compliance of a 14-day vonopr...
Saved in:
Main Authors: | Jin-Yan Zhang, Jin-Hai Chen, Yu-Lin Huang, Ji Li, Dong Xu, Zhong Xu, Xiao-Yi Lei |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-07-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848251354868 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of bismuth quadruple regimens containing minocycline and vonoprazan for eradication of Helicobacter pylori: Real‐world evidence
by: Qiyunna He, et al.
Published: (2024-05-01) -
A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis
by: Sung Eun Kim, et al.
Published: (2021-03-01) -
Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication
by: Jin Hee Noh, et al.
Published: (2023-09-01) -
Comparison of Tegoprazan- and Lansoprazole-Based Fourteen-Day Triple Therapies as First-Line Treatments for Eradication
by: Seokin Kang, et al.
Published: (2024-06-01) -
Efficacy of Bismuth-based Quadruple Therapy as First-line Treatment for Clarithromycin-resistant Helicobacter pylori Infection
by: Seung In Seo, et al.
Published: (2022-09-01)